Skip to content
Peptide Spencer
Partner

Growth hormone axis

Tesamorelin

  • 10 mg
  • 20 mg

Custom strengths on request

FDA-approved as Egrifta SV and Egrifta WR. Compounded tesamorelin is not FDA-approved. Source, Jul 31, 2026

At a glance

These dosages are a helpful guide, not a prescription. Every clinician is expected to do their own due diligence before prescribing.

  1. Start

    1.4 mg subcutaneously once daily (EGRIFTA SV)

    Approved label
Frequency
Once daily
Route
Subcutaneous injection into the abdomen, rotating sites
Course
Pivotal trials: 26 weeks plus a 26-week extension
Label doses apply only to branded EGRIFTA vials; recalculate volume for compounded vials from the pharmacy's labeled mg/mL.
Calculate this dose

Full dosing guide

Get a quote

Custom strengths on request. Prices are quoted per clinic.